This is a StreetInsider.com Premium Only Page

Galapagos NV (GLPG) –

Apr 17, 2024 08:17 AM Galapagos NV (GLPG:NA) (GLPG) PT Lowered to EUR30 at Citi

Apr 8, 2024 09:28 AM Form 6-K GALAPAGOS NV For: Apr 04

Mar 29, 2024 05:08 PM Form 6-K GALAPAGOS NV For: Mar 29

Mar 29, 2024 06:15 AM Form 6-K GALAPAGOS NV For: Mar 26

Mar 28, 2024 04:09 PM Form 20-F GALAPAGOS NV For: Dec 31

Mar 28, 2024 06:43 AM BofA Securities Downgrades Galapagos NV (GLPG) to Underperform

Mar 7, 2024 08:46 AM Morgan Stanley Assumes Galapagos NV (GLPG) at Equalweight

Feb 26, 2024 04:30 AM UBS Reiterates Neutral Rating on Galapagos NV (GLPG:NA) (GLPG)

Feb 26, 2024 04:02 AM Galapagos NV (GLPG:NA) (GLPG) PT Lowered to EUR33 at Barclays

Feb 23, 2024 06:42 AM Form 6-K GALAPAGOS NV For: Feb 22

Feb 23, 2024 05:29 AM UBS Reiterates Neutral Rating on Galapagos NV (GLPG:NA) (GLPG)

Feb 16, 2024 06:02 AM Form 6-K GALAPAGOS NV For: Feb 15

Feb 14, 2024 05:42 PM Form SC 13G/A GALAPAGOS NV Filed by: EcoR1 Capital, LLC

Feb 9, 2024 09:04 AM Form SC 13G/A GALAPAGOS NV Filed by: FMR LLC

Feb 6, 2024 06:02 AM Form 6-K GALAPAGOS NV For: Jan 31

Jan 5, 2024 06:00 AM Form 6-K GALAPAGOS NV For: Jan 04

Jan 4, 2024 04:07 PM Form 6-K GALAPAGOS NV For: Jan 03

Jan 4, 2024 04:05 PM Form 6-K GALAPAGOS NV For: Jan 02

Jan 3, 2024 04:02 PM BridGene Biosciences Announces Strategic Collaboration with Galapagos (GLPG)

Jan 3, 2024 04:01 PM BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology Targets

Dec 21, 2023 04:04 PM Form 6-K GALAPAGOS NV For: Dec 19

Dec 19, 2023 04:01 PM Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301

Dec 19, 2023 02:37 AM Deutsche Bank Reiterates Hold Rating on Galapagos NV (GLPG:NA) (GLPG)

Dec 12, 2023 07:03 AM Form 6-K GALAPAGOS NV For: Dec 09

Dec 12, 2023 06:02 AM Form 6-K GALAPAGOS NV For: Dec 07

Dec 5, 2023 07:21 AM Galapagos NV (GLPG) PT Lowered to $37 at JPMorgan

Dec 5, 2023 02:20 AM Galapagos NV (GLPG:NA) (GLPG) PT Lowered to EUR34 at JPMorgan

Dec 4, 2023 05:17 PM Form S-8 GALAPAGOS NV

Nov 24, 2023 02:07 AM Galapagos NV (GLPG:NA) (GLPG) PT Lowered to EUR35 at Citi

Nov 6, 2023 09:47 AM Galapagos NV (GLPG) PT Lowered to $41 at BofA Securities

Nov 6, 2023 07:45 AM Galapagos NV (GLPG) and Landmark Bio Enter Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care

Nov 6, 2023 07:45 AM Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care

Nov 3, 2023 08:26 AM Form 6-K GALAPAGOS NV For: Nov 02

Nov 2, 2023 07:16 AM Form 6-K GALAPAGOS NV For: Oct 30

Sep 20, 2023 06:03 AM Form 6-K GALAPAGOS NV For: Sep 19

Sep 5, 2023 06:26 AM Galapagos NV (GLPG:NA) (GLPG) PT Lowered to EUR36 at Morgan Stanley

Aug 30, 2023 06:32 AM Form 6-K GALAPAGOS NV For: Aug 28

Aug 24, 2023 08:51 AM Citi Downgrades Galapagos NV (GLPG:NA) (GLPG) to Neutral

Aug 7, 2023 08:00 AM Galapagos NV (GLPG) PT Lowered to $40 at Morgan Stanley

Aug 7, 2023 06:24 AM Galapagos NV (GLPG) PT Lowered to $38 at RBC Capital

Aug 4, 2023 04:06 PM Form 6-K GALAPAGOS NV For: Aug 04

Aug 4, 2023 01:20 PM Galapagos NV (GLPG) PT Lowered to $40 at Morgan Stanley

Jun 15, 2023 05:03 PM Form 6-K GALAPAGOS NV For: Jun 15

Jun 13, 2023 07:54 AM Form 6-K GALAPAGOS NV For: Jun 13

Jun 12, 2023 07:32 AM Form 6-K GALAPAGOS NV For: Jun 12

Jun 7, 2023 04:45 PM Form SC 13G GALAPAGOS NV Filed by: EcoR1 Capital, LLC

May 31, 2023 06:55 AM Galapagos NV (GLPG) PT Lowered to $45 at JPMorgan

May 31, 2023 03:28 AM Galapagos NV (GLPG:NA) (GLPG) PT Lowered to EUR42 at JPMorgan

May 26, 2023 06:01 AM Form 6-K GALAPAGOS NV For: May 23

May 23, 2023 07:30 AM Form 6-K GALAPAGOS NV For: May 22